[Clinical and laboratory characteristics and results of treatment of patients with ACTH-producing neuroendocrine tumors of various localization].

Olga Golounina Zhanna Belaya Liudmila Ya Rozhinskaya E I Marova M Y Pikunov P M Khandaeva S D Arapova Larisa K Dzeranova N S Kuznetsov Valentin V Fadeev Galina A Melnichenko Ivan I Dedov

Published in: Terapevticheskii arkhiv (2021)

In our cohort of patients bronchopulmonary NET are the most frequent cause of EAS (62.3%). Surgical treatment leads to remission of hypercortisolism in 72% cases; the proportion of relapse (14.6%) and fatal outcome (20%) remains frequent in EAS.

Keyphrases

neuroendocrine tumors
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes
ulcerative colitis
replacement therapy